![]() |
市场调查报告书
商品编码
1547364
全球 NGS 样本製备市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测Global NGS Sample Preparation Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球NGS样本製备市场需求预计将从2023年的15.4亿美元达到2032年近62.3亿美元的市场规模,2024-2032年研究期间复合年增长率为16.76%。
NGS(次世代定序)样本製备准备用于定序的生物样本以分析遗传物质。这项准备工作涉及几个关键步骤:从细胞中提取 DNA 或 RNA、片段化核酸以及添加用于定序的接头。然后将製备好的样品进行扩增以建立可定序的文库。 NGS 样本製备的进步简化了工作流程、提高了效率并降低了成本,使高通量定序能够应用于基因组学、肿瘤学、传染病和个人化医疗。准确的样本製备对于获得可靠的定序资料以及深入了解遗传变异、疾病机制和演化生物学至关重要。
下一代定序 (NGS) 技术在研究和临床环境中的使用越来越多,这是因为它们能够快速、经济高效地提供全面的基因组信息,这推动了 NGS 样本製备市场的成长。自动化平台和优化方案等样品製备技术的进步正在提高 NGS 工作流程的效率和准确性,从而推动市场需求。遗传性疾病盛行率的上升和对个人化医疗的关注推动了对高通量和可靠的 NGS 样本製备方法的需求。此外,增加对基因组研究的投资和扩大新兴市场的定序能力也有助于市场成长。
学术机构、研究组织和生物技术公司之间的合作正在促进新型 NGS 样品製备解决方案的创新和开发。对在临床诊断中使用 NGS 的监管支持以及将 NGS 融入常规医疗实践的持续趋势进一步推动了市场扩张。 NGS 新应用(例如肿瘤学、传染病诊断和生殖健康)的持续发展也增加了对高效能样本製备技术的需求。然而,测序技术的高成本、对高技能人员的需求以及资料分析的复杂性可能会阻碍未来几年的市场成长。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具还对全球 NGS 样品製备市场的各个细分市场进行了包容性评估。 NGS 样品製备市场产业的成长和趋势为本研究提供了整体方法。
NGS 样品製备市场市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲 NGS 样品製备市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。 NGS 样本製备市场的主要参与者包括 Qiagen、Thermo Fisher Scientific Inc.、Merck KGaA、F. Hoffmann-La Roche Ltd.、Agilent Technologies、Promega Corporation、Illumina Inc.、Integrated DNA Technologies Inc.、New England Biolabs ,Tecan贸易股份公司。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for NGS Sample Preparation Market is presumed to reach the market size of nearly USD 6.23 Billion by 2032 from USD 1.54 Billion in 2023 with a CAGR of 16.76% under the study period 2024-2032.
NGS (Next-Generation Sequencing) sample preparation prepares biological samples for sequencing to analyze genetic material. This preparation involves several key steps: extracting DNA or RNA from cells, fragmenting the nucleic acids, and adding adapters for sequencing. The prepared samples are then amplified to create a library that can be sequenced. Advances in NGS sample preparation have streamlined workflows, increased efficiency, and reduced costs, enabling high-throughput sequencing for applications in genomics, oncology, infectious diseases, and personalized medicine. Accurate sample preparation is crucial for obtaining reliable sequencing data and achieving insights into genetic variations, disease mechanisms, and evolutionary biology.
The growing use of next-generation sequencing (NGS) technologies in research and clinical settings is driven by their capacity to provide comprehensive genomic information quickly and cost-effectively, which is driving the growth of the NGS sample preparation market. Advancements in sample preparation techniques, such as automated platforms and optimized protocols, are improving the efficiency and accuracy of NGS workflows, thereby boosting market demand. Genetic disorders' rising prevalence and focus on personalized medicine propel the need for high-throughput and reliable NGS sample preparation methods. Additionally, increasing investments in genomic research and expanding sequencing capabilities in emerging markets contribute to market growth.
Collaborations between academic institutions, research organizations, and biotechnology companies are fostering innovation and the development of novel NGS sample preparation solutions. Regulatory support for using NGS in clinical diagnostics and the ongoing trend of integrating NGS into routine medical practice further drive market expansion. The continuous development of new applications for NGS, such as in oncology, infectious disease diagnostics, and reproductive health, is also enhancing the demand for efficient sample preparation technologies. However, the high costs of sequencing technologies, the need for highly skilled personnel, and the complexity of data analysis may hinder market growth in the next few years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of NGS Sample Preparation Market. The growth and trends of NGS Sample Preparation Market industry provide a holistic approach to this study.
This section of the NGS Sample Preparation Market market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the NGS Sample Preparation Market market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the NGS Sample Preparation Market market include Qiagen, Thermo Fisher Scientific Inc., Merck KGaA, F. Hoffmann-La Roche Ltd., Agilent Technologies, Promega Corporation, Illumina Inc., Integrated DNA Technologies Inc., New England Biolabs, Tecan Trading AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.